NEWS RELEASE: VitalPath Appoints Aimee Moore as Chief Financial Officer
VitalPath CFO Aimee Moore [Photo courtesy of VitalPath]
New Hope, Minn. — VitalPath, a leading Contract Development and Manufacturing Organization (CDMO) specializing in complex catheters and precision laser components, announced the appointment of Aimee Moore as Chief Financial Officer (CFO).
Ms. Moore initially joined VitalPath in 2024 as Interim CFO, where she quickly made a significant impact by strengthening financial strategy and supporting the company’s long-term growth initiatives.
“We are thrilled to welcome Aimee as our permanent CFO,” said Bill Ellerkamp, CEO of VitalPath. “She’s a results-driven leader who isn’t afraid to roll up her sleeves. Her hands-on approach and ability to elevate our financial strategy have already made her an invaluable asset. I’m excited to continue working alongside her as we accelerate VitalPath’s growth trajectory.”
With over 29 years of progressive accounting and financial leadership experience, Ms. Moore has built a career as a trusted business partner to executive teams delivering accurate, timely financial insights that drive informed decision-making. Her previous roles include leadership positions at Alpine Software Group, Spartronics LLC, Cliq Studios, Cogentix Medical, and Salo LLC..
“I’m honored to officially step into the CFO role at VitalPath,” said Ms. Moore. “There’s a deep sense of purpose in being part of a company so committed to improving patients’ lives. I look forward to partnering with Bill and the executive leadership team to drive financial excellence, enhance operational efficiency, and continue expanding our impact in the market.”
Ms. Moore is a CPA (inactive) and holds a bachelor’s degree in accounting from the Carlson School of Management at the University of Minnesota, as well as a bachelor’s degree in Spanish and Government from the University of Virginia.
About VitalPath
In partnership with our customers, VitalPath is driven to help dramatically improve quality of life for patients around the world. We do this by delivering exceptional, high-quality complex catheter solutions through impassioned customer relationships, innovative engineering, and operational excellence. In doing so, we serve our customers as well as our employees, their families, our suppliers, our communities, and our investors. The VitalPath team specializes in meeting customers’ most challenging complex catheter design and manufacturing requirements, built on a comprehensive suite of precision component manufacturing capabilities.
The company is ISO 13485:2016 certified with an FDA registered site, including ISO 7 & 8 cleanrooms.
For more information, visit https://vitalpath.com/ and follow VitalPath on LinkedIn
About Inverness Graham Investments
Inverness Graham is a Philadelphia based buyout firm focused on acquiring innovative, high-growth companies where technology is transforming traditional industry. The firm’s Flagship strategy focuses on businesses in Healthcare, Tech-Enabled Services / Software and Advanced Manufacturing. The firm’s Green Light strategy targets tech-enabled businesses where Environmental Sustainability is a key driver of accelerating growth. Inverness Graham executes a differentiated, repeatable model for value creation through its proprietary Strategic Platform Build approach. Founded by senior executives of the Graham Group, the firm builds upon a 60-year legacy of operational excellence, bringing substantial value creation resources and an innovative mindset to support its portfolio company partners.
For more information, visit https://www.invernessgraham.com/
The opinions expressed in this news release are the author’s only and do not necessarily reflect those of Medical Design & Outsourcing or its employees.
